Meadow Creek Investment Management’s Medicines Co MDCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$410K Buy
8,192
+384
+5% +$15.3K 0.01% 788
2019
Q2
$285K Buy
7,808
+224
+3% +$7.31K 0.01% 923
2019
Q1
$212K Hold
7,584
﹤0.01% 997
2018
Q4
$145K Buy
7,584
+1,712
+29% +$39.8K ﹤0.01% 1062
2018
Q3
$176K Buy
5,872
+1,184
+25% +$44.6K ﹤0.01% 1108
2018
Q2
$172K Buy
4,688
+208
+5% +$6.76K ﹤0.01% 1040
2018
Q1
$148K Hold
4,480
﹤0.01% 1096
2017
Q4
$122K Buy
4,480
+640
+17% +$19.7K ﹤0.01% 1153
2017
Q3
$142K Buy
3,840
+528
+16% +$19.5K ﹤0.01% 1045
2017
Q2
$126K Buy
3,312
+1,424
+75% +$63.4K ﹤0.01% 1023
2017
Q1
$92K Buy
1,888
+208
+12% +$9.49K ﹤0.01% 975
2016
Q4
$57K Buy
+1,680
New +$59.6K ﹤0.01% 1088

Other funds holding MDCO

Meadow Creek Investment Management's MDCO Position: Q3 2019 in Review

Meadow Creek Investment Management increased its Medicines Co (MDCO) stake by 4.9% in Q3 2019, buying an estimated $15.3K and bringing the position to 8,192 shares worth $410K. The position accounts for 0.01% of the portfolio, ranked #788.

Meadow Creek Investment Management first reported a position in MDCO in Q4 2016 and has held it in 12 quarters since. 250 funds tracked by Wall St. Rank hold MDCO as of Q3 2019.

  • Meadow Creek Investment Management held 8,192 shares of Medicines Co worth $410K as of Q3 2019.
  • Meadow Creek Investment Management bought 384 Medicines Co shares in Q3 2019, an estimated $15.3K.
  • Medicines Co made up 0.01% of Meadow Creek Investment Management's portfolio in Q3 2019, its #788 holding.
  • Meadow Creek Investment Management first reported a position in Medicines Co in Q4 2016 and has held it in 12 quarters since.
  • 250 funds tracked by Wall St. Rank held Medicines Co as of Q3 2019.

Based on Meadow Creek Investment Management's 13F filing for Q3 2019, filed 14 Nov 2019.